CN107569514A - It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene - Google Patents
It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene Download PDFInfo
- Publication number
- CN107569514A CN107569514A CN201710914788.0A CN201710914788A CN107569514A CN 107569514 A CN107569514 A CN 107569514A CN 201710914788 A CN201710914788 A CN 201710914788A CN 107569514 A CN107569514 A CN 107569514A
- Authority
- CN
- China
- Prior art keywords
- extract
- concentration
- activated complex
- metal ion
- anthocyanin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of activated complex for targetting raising p53 expression of tumor suppressor gene, the activated complex is chelated by the raw material including following components and obtained:Anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、Mg2+、Mn2+、Mo2+、K+、Rb+And Li+.Harmful free radicals are eliminated from anthocyanin, the several kinds of mineral elements ion of participation enzymic catalytic reaction and vitamin confactor (Cofacter (s)), P53 action target matrix metalloproteinases MMP, hypoxia inducible factor HIF, MDM2 zinc finger protein (structure is easily distorted by heavy metal ion), miRNA nickases Dicer regulation and control are started with, " enclosing target " (Encircle Target) regulation is carried out to P53 genes, reach control cancer cell development, induce cancer cell aging and death.
Description
Technical field
The present invention relates to targeting to press down cancer drug technical field, and in particular to a kind of target improves p53 expression of tumor suppressor gene
Activated complex.
Background technology
Cancer is a kind of genopathy, is under the effect of outer environmental factor, is activated in human body cell in a variety of preceding oncogenes
With the process of the multistage long term evolution of tumor suppressor gene inactivation.Before accurate medical technology maturation, the primary treatment hand of cancer
Section is radiotherapy, chemotherapy and operation, although this three big treatment means of physicians' constantly improve, many cancer patients are still difficult to
Cured.One of major reason is that the microenvironment of gene mutation is not intervened at all.With gene sequencing technology
Maturation, particularly enzymatic activity control, the sharpening of DNA biochemical mechanisms, gene target intervention turn into precisely medical treatment important hair
Open up direction.
According to《Science》A research that magazine in August, 2017 is delivered shows that the gene expression for having 17 kinds of cancers has very big
It is overlapping.This means for some patients, their gene expression is possible to more be close to other kinds of cancer,
Rather than the cancer suffered from itself.
P53 is a kind of tumor suppressor gene (Tumor suppressorgene), by the protein of this gene code
(protein) it is a kind of transcription factor (transcriptional factor), which control the startup of cell cycle.P53 bases
Because be find so far with human tumor correlation highest gene, it is p53 bases to cause tumour formation or the p53 albumen of cell transformation
It is a kind of tumor promotion factor because of the product of mutation, it can eliminate normal p53 function.Malignant tumour more than 50%
Patient (including liver cancer, breast cancer, carcinoma of urinary bladder, stomach cancer, colon cancer, prostate cancer, soft tissue sarcoma, oophoroma, brain tumor, lymph
Cell tumour, cancer of the esophagus, lung cancer, osteogenic sarcoma etc.) mutation of p53 genes occurs in vivo.To this phase in each cancer kind of P53
Guan Xing, Duplication highest gene expression are effectively adjusted, and have certain directive significance for targeted therapy.
It is less for the drug research of p53 targeted therapies at present, for p53 genes still without a kind of effective, more site targets
To the medicine of intervention.
The content of the invention
It is an object of the invention to provide a kind of activated complex for targetting raising p53 expression of tumor suppressor gene.
The invention provides it is a kind of target improve p53 expression of tumor suppressor gene activated complex, the activated complex by
Raw material chelating including following components obtains:Anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、
Mg2+、Mn2+、Mo2+、K+、Rb+And Li+In one or more.
Present invention also offers a kind of activated complex solution for targetting raising p53 expression of tumor suppressor gene, the activity is multiple
The solvent of polymer solution is water, and solute includes anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、
Mg2+、Mn2+、Mo2+、K+、Rb+And Li+In one or more.
Preferably, concentration of the anthocyanin in activated complex solution is 1~100mg/ml.
Preferably, the anthocyanin is plant extract anthocyanin, and the plant includes purple sweetpotato, grape, blood is orange, red ball is sweet
One or more in indigo plant, blueberry, eggplant, cherry, the red certain kind of berries, strawberry, mulberries, hawthorn and morning glory.
Preferably, the mass content of anthocyanin is 3~50% in the plant extract anthocyanin.
Preferably, concentration of the metal ion in activated complex solution is as follows:Fe2+Concentration for 0.1~
0.4mg/ml, Ca2+Concentration be 0.2~20mg/ml, Zn2+Concentration be 0.04~0.38mg/ml, Se2+Concentration be
0.0001~0.004mg/ml, Mg2+Concentration be 0.4~7mg/ml, Mn2+Concentration be 0.0004~0.06mg/ml, Mo2+'s
Concentration is 0.0002~0.007mg/ml, K+Concentration be 0.4~112.5mg/ml, Rb+Concentration for 0.0004~
0.0952mg/ml, Li+Concentration be 0.0004~0.012mg/ml.
Preferably, concentration of the metal ion in activated complex solution is as follows:Fe2+Concentration for 0.2~
0.3mg/ml, Ca2+Concentration be 0.5~15mg/ml, Zn2+Concentration be 0.15~0.28mg/ml, Se2+Concentration be
0.0002~0.003mg/ml, Mg2+Concentration be 1.5~6mg/ml, Mn2+Concentration be 0.01~0.05mg/ml, Mo2+It is dense
Spend for 0.0008~0.006mg/ml, K+Concentration be 5~100mg/ml, Rb+Concentration be 0.002~0.08mg/ml, Li+'s
Concentration is 0.001~0.012mg/ml.
Preferably, the metal ion derives from the active ionic water purified with mineral matter.
Preferably, the metal ion derives from the plant extracts rich in metal ion, including Fe2+Extract, Ca2+
Extract, Zn2+Extract, Se2+Extract, Mg2+Extract, Mn2+Extract, Mo2+Extract, K+Extract, Rb+Extract
And Li+Extract.
Preferably, the Fe2+Extract is cherry extract, the Ca2+Extract include mass ratio for (0.9~
1.1):(0.9~1.1) Thallus Laminariae (Thallus Eckloniae) extract and Herba Apii graveolentis extract;The Zn2+Extract includes mass ratio (0.9~1.1):(0.9
~1.1):Abelmoschus Esculentus Linn extract, blueberry extract and the male silk moth extract of (0.9~1.1);The Se2+Extract, Rb+Carry
It is marine algae extract to take thing;The Mg2+Extract includes mass ratio (0.9~1.1):(0.9~1.1):The hazel of (0.9~1.1)
Seed extract, Semen phaseoli radiati extract and thyme extract;The Mn2+Extract includes mass ratio (0.9~1.1):(0.9~
1.1) Echinacea Purpurea Herb P.E and green-tea extract;The Mo2+Extract is extract of soybean;The K+Extract includes quality
Than (0.9~1.1):(0.9~1.1):(0.9~1.1):Thallus Laminariae (Thallus Eckloniae) extract, banana extract, the dried peppermint leaf of (0.9~1.1) carry
Take thing and wax gourd extract;The Li+Extract is to spread out numb tea extraction.
Beneficial effects of the present invention:The activated complex is obtained by being chelated by the raw material including following components:Anthocyanin
And metal ion, the existence form of the chelate enable the metal ion in the activated complex to smoothly complete including wearing
Microcirculation transport inside more including blood-brain barrier.The present invention starts with from the regulation and control of the following aspects, including:1) anthocyanin pair
Harmful free radicals eliminate;2) the various metals ion and vitamin confactor (Cofacter (s)) of enzymic catalytic reaction are participated in;3)
P53 action target matrix metalloproteinases MMP;4) hypoxia inducible factor HIF;5) (structure is easily by heavy metal for MDM2 zinc finger proteins
Ion is distorted);6) miRNA nickases Dicer, " enclosing target " (Encircle Target) regulation is carried out to P53 genes, reverses DNA
Methylate and activate repressed p53 activity, increase and Time of Administration with anthocyanin and concentration of metal ions in tumour cell
Increase, p53 protein expressions dramatically increase, and p53 gene methylation situations significantly reduce.Recorded according to embodiment, pass through three
The clinical intervention validity check control of first hospital, after more than 65 patients take activated complex of the present invention, blood closes
Key immune indexes, tumor markers index are obviously controlled or recover normal completely.
Embodiment
The invention provides it is a kind of target improve p53 expression of tumor suppressor gene activated complex, the activated complex by
Raw material chelating including following components obtains:Anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、
Mg2+、Mn2+、Mo2+、K+、Rb+And Li+In one or more.
Present invention also offers a kind of activated complex solution for targetting raising p53 expression of tumor suppressor gene, the activity is multiple
The solvent of polymer solution is water, and solute includes anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、
Mg2+、Mn2+、Mo2+、K+、Rb+And Li+In one or more.
In the present invention, the anthocyanin is preferably derived from plant extracts, and the plant includes purple sweetpotato, grape, blood
One or more in orange, red cabbage, blueberry, eggplant, cherry, the red certain kind of berries, strawberry, mulberries, hawthorn and morning glory.The present invention is right
The extracting method of the anthocyanin is not particularly limited, using the technical scheme of the conventional extraction anthocyanin in this area.
It is prepared by the commission of anthocyanin described in specific implementation process of the present invention Daxing'an Mountainrange Lin Gebei psychrophiles Science and Technology Co., Ltd.
Obtain.The mass content of anthocyanin is preferably 3~50% in the plant extract anthocyanin in the present invention, more preferably
10~30%.
In the present invention, the concentration of anthocyanin is preferably 1~100mg/ml in the activated complex solution, more preferably
For 2~60mg/ml, most preferably 3~10mg/ml.In the present invention, the anthocyanin act as:Supplied as hydroxyl
Body, its phenol type structure make it have anti-oxidation function, by scavenging capacity chalcogen (ROS), such as oxygen radical (O2-), singlet oxygen
(O2), peroxide (ROO-), hydrogen peroxide (H2O2) and hydroxy radical (OH-) etc. oxidation reaction enliven intermediary's material, induction
P53 is expressed.
In the present invention, anthocyanin is combined preferably as carrier with metal ion, forms chelate, the chelate
Existence form enable the metal ion be smoothly rapidly completed including passing through blood-brain barrier inside microcirculation transport.
The state of the chelate has no effect on the performance of the anthocyanin effect, and the sequestering properties are advantageous to by carrier of anthocyanin
Promote metal ion fast transportation in vivo and absorption;After the metal ion is entered in vivo with chelate state, according to need
Dissociated or recombined on anthocyanin accordingly.
In the present invention, the activated complex solution includes metal cations Fe2+, preferable described Fe2+From with
Iron content mineral matter purification active ionic water or from rich in Fe2+Plant extracts, the mineral matter of the iron content carries
Pure active ionic water preferably entrusts Qingdao Shen Dongkuang liquid Co., Ltd to prepare;The Fe2+Extract is cherry extract.This
In activated complex solution described in invention, Fe2+Concentration is preferably 0.1~0.4mg/ml, more preferably 0.2~0.3mg/
ml.Heretofore described Fe2+It act as:Hemoglobin ferrous ion is supplemented, increase hemoglobin synthesis, activates the work of oxygenase
Property, strengthen blood oxygen concentration;Suppression of the nearly and complementary enhancing p53 to hypoxia inducible factor HIF;The enhancing of oxonium ion, is also helped
Maintained vigour in Ubiquitin-proteasome, HIF-l α subunits is kept reduced levels.
In the present invention, the activated complex solution includes metallic ions Ca2+, preferable described Ca2+From with
Calcic mineral matter purification active ionic water or from rich in Ca2+Plant extracts, the Ca2+Extract is sea
Band extract and Herba Apii graveolentis extract.The Ca2+The mass ratio of Thallus Laminariae (Thallus Eckloniae) extract and Herba Apii graveolentis extract is preferably in extract
(0.9~1.1):(0.9~1.1), more preferably 1:1;In heretofore described activated complex solution, Ca2+Concentration is preferred
For 0.2~20mg/ml, more preferably 0.5~15mg/ml.Heretofore described Ca2+It act as:Fibrinolysin is activated with swashing
Peptide discharges enzyme, and resolution improves fibrinolytic, reduces fiber protein content in blood plasma, reduces cancer embolus generation and tissue fibers wind transmission
Danger.
In the present invention, the activated complex solution includes configuration metal ions Zn2+, preferable described Zn2+From with
Containing zinc mineral matter purification active ionic water or from rich in Zn2+Plant extracts, the Zn2+Extract includes
Abelmoschus Esculentus Linn extract, blueberry extract and male silk moth extract;The Abelmoschus Esculentus Linn extract, blueberry extract and male silk moth extraction
The mass ratio (0.9~1.1) of thing:(0.9~1.1):(0.9~1.1), more preferably 1:1:1.Heretofore described activity is multiple
In polymer solution, Zn2+Concentration is preferably 0.04~0.38mg/ml, more preferably 0.15~0.28mg/ml.In the present invention
The Zn2+It act as:Cd in zinc finger protein structure is distorted in displacement2+、Hg2+、Co2+、Cu2+, while suppress Metal Ions Cd2+、Hg2 +、Co2+、Cu2+Absorption and enzymatic reaction activity.
In the present invention, the activated complex solution includes metal ion Se2+, preferable described Se2+From with
Containing selenium mineral matter purification active ionic water or from rich in Se2+Plant extracts, the Se2+Extract is sea
Algae extract.In heretofore described activated complex solution, Se2+Concentration is preferably 0.0001~0.004mg/ml, more excellent
Choosing for 0.0002~0.003mg/ml.Heretofore described Se2+As:Cd in zinc finger protein structure is distorted in displacement2+、Hg2+、
Co2+、Cu2+, while suppress Metal Ions Cd2+、Hg2+、Co2+、Cu2+Absorption and enzymatic reaction activity.
In the present invention, the activated complex solution includes metal ions M g2+, preferable described Mg2+From with
Containing magnesium mineral matter purification active ionic water or from rich in Mg2+Plant extracts, the Mg2+Extract includes
Hazel extract, Semen phaseoli radiati extract and thyme extract, the hazel extract, Semen phaseoli radiati extract and thyme extract
Mass ratio is preferably (0.9~1.1):(0.9~1.1):(0.9~1.1), more preferably 1:1:1.Heretofore described work
In property complex solution, Mg2+Concentration is preferably 0.4~7mg/ml, more preferably 1.5~6mg/ml.It is heretofore described
Mg2+Effect includes the conservative amino acid residues site with reference to Dicer enzymatics center, Dicer is attached to dsRNA, triggers big
The cutting mRNA reactions of amount, obtain miRNA precursors;The direct action target miRNA of p53, apoptosis-induced, aging and cell cycle stop
It is stagnant.The Mg2+Effect also includes and Mn2+, K+And Rb+Collective effect activation pyruvate kinase (pyruvate kinase, PK),
In glycolysis system, it is the enzyme that catalysis forms second ATP reaction.In ATP and Mg2+Under participation, fructose-1, 6-diphosphate kinases 1
(6-phosphofructokinase1, PFK1) in glycolytic pathway, catalysis fructose-1, 6-diphosphate generates fructose 1,6-diphosphate
(Fructosel, 6bisphosphate, F-1,6-BP), accelerate second of phosphorylation reaction of glycolytic pathway, improve activity
Oxygen content, make cancer cell that the mechanism of apoptosis occur.
In the present invention, the activated complex solution includes metal ions M n2+, preferable described Mn2+From with
Containing manganese mineral matter purification active ionic water or from rich in Mn2+Plant extracts, the Mn2+Extract includes
Echinacea Purpurea Herb P.E and green-tea extract, the mass ratio of the Echinacea Purpurea Herb P.E and green-tea extract be preferably (0.9~
1.1):(0.9~1.1), more preferably 1:1.In heretofore described activated complex solution, Mn2+Concentration is preferably
0.0004~0.06mg/ml, more preferably 0.01~0.05mg/ml.Heretofore described Mn2+Effect includes combining Dicer
The conservative amino acid residues site at enzymatic center, Dicer is attached to dsRNA, trigger substantial amounts of cutting mRNA reactions, obtain
MiRNA precursors;The direct action target miRNA of p53, apoptosis-induced, aging and cell cycle arrest.The Mn2+Effect also includes
With Mg2+, K+And Rb+Collective effect activation pyruvate kinase (pyruvate kinase, PK), in glycolysis system, it is to urge
Change the enzyme for forming second ATP reaction.Active o content is improved, makes cancer cell that the mechanism of apoptosis occur.The Mn2+Effect is also wrapped
Include by supplementing Mn2+Intake, Intramitochondrial manganese is supplemented, increase hemoglobin synthesis, the activity of oxygenase is activated, strengthens blood oxygen
Concentration;Suppression of the nearly and complementary enhancing p53 to hypoxia inducible factor HIF;The enhancing of oxonium ion, it helps ubiquitin protein enzyme
Body maintains vigour, and HIF-l α subunits is kept reduced levels.
In the present invention, the activated complex solution includes metal ions M o2+, preferable described Mo2+From with
Containing molybdenum mineral matter purification active ionic water or from rich in Mo2+Plant extracts, the Mo2+Extract is big
Beans extract.In heretofore described activated complex solution, Mo2+Concentration is preferably 0.0002~0.007mg/ml, more excellent
Choosing for 0.0008~0.006mg/ml.Heretofore described Mo2+Effect includes passing through Mo2+Balance and suppression Cu2+Activity and
Absorb, suppress LOX to p53 hydroxylating, the Mo2+Effect also distorts Cd in zinc finger protein structure including displacement2+、Hg2+、Co2 +、Cu2+, while suppress Metal Ions Cd2+、Hg2+、Co2+、Cu2+Absorption and enzymatic reaction activity.
In the present invention, the activated complex solution includes metal ion K+, preferable described K+From with containing potassium
Mineral matter purification active ionic water or from rich in K+Plant extracts, the K+Extract extracts including sea-tangle
Thing, banana extract, peppermint leaf extract and wax gourd extract, the Thallus Laminariae (Thallus Eckloniae) extract, banana extract, peppermint leaf extract
(0.9~1.1) is preferably with the mass ratio of wax gourd extract:(0.9~1.1):(0.9~1.1):(0.9~1.1), it is more excellent
Choosing for 1:1:1:1.K in heretofore described activated complex solution+Concentration is preferably 0.4~112.5mg/ml, more excellent
Choosing for 5~100mg/ml.Heretofore described K+It act as by supplementing K+、Li+And Ca2+Fibrinolysin is activated to discharge with kassinin kinin
Enzyme, resolution improve fibrinolytic, reduce fiber protein content in blood plasma, reduce cancer embolus generation and tissue fibrosis risk.
In the present invention, the activated complex solution includes metal ion Rb+, preferable described Rb+From with containing
Rubidium mineral matter purification active ionic water or from rich in Rb+Plant extracts, the Rb+Extract carries for marine alga
Take thing.In heretofore described activated complex solution, Rb+Concentration is preferably 0.0004~0.0952mg/ml, more preferably
For 0.002~0.08mg/ml.Heretofore described Rb+It act as and Mg2+, Mn2+And K+Collective effect activates pyruvate kinase
(pyruvate kinase, PK), in glycolysis system, it is the enzyme that catalysis forms second ATP reaction.In ATP and Mg2+
Under participation, fructose-1, 6-diphosphate kinases 1 (6-phosphofructokinase1, PFK1) is catalyzed 6- phosphoric acid in glycolytic pathway
Fructose generation fructose 1,6-diphosphate (Fructosel, 6bisphosphate, F-1,6-BP), accelerates the second of glycolytic pathway
Hypophosphorous acidization is reacted, and improves active o content, makes cancer cell that the mechanism of apoptosis occur.
In the present invention, the activated complex solution includes metal ion Li+, preferable described Li+From with containing
Lithium mineral matter purification active ionic water or from rich in Li+Plant extracts, the Li+Extract is bluish dogbane
Wooden tea extraction.In heretofore described activated complex solution, Li+Concentration is preferably 0.0004~0.012mg/ml, more
Preferably 0.001~0.012mg/ml.Heretofore described Li+It act as by supplementing Li+Fibrinolysin is activated to discharge with kassinin kinin
Enzyme, resolution improve fibrinolytic, reduce fiber protein content in blood plasma, reduce cancer embolus generation and tissue fibrosis risk.
In the present invention, above-mentioned metal ion preferably derives from contains Fe simultaneously2+、Ca2+、Zn2+、Se2+、Mg2+、Mn2+、
Mo2+、K+、Rb+、Li+Mineral matter purification active ionic water, the mineral matter comprising above-mentioned metal ion purifies active ion
Water preferably entrusts mining company to process, and Qingdao Shen Dongkuang liquid Co., Ltd is entrusted in specific implementation process of the present invention.
The method that the present invention extracts to obtain metal ion to above-mentioned plant source is not particularly limited, and is routinely carried using this area
Method is taken, specifically in implementation process of the present invention, entrusts the limited public affairs of Daxing'an Mountainrange Lin Gebei psychrophile science and technology shares
Department's processing.
The preparation method of the activated complex is dissolved in for cyanine glucoside extract is mixed with metal ion in the present invention
Chelate is formed in water.In activated complex preparation process of the present invention the concentration of anthocyanin and the concentration of metal ion referring to
The concentration of anthocyanin and metal ion in above-mentioned activated complex solution, will not be repeated here.
In the present invention, the albumen for p53 gene expressions is distributed mainly on cell caryoplasm, can be with DNA specific bonds, its
Activity by phosphorylation, acetylation, methylate, the characteristic such as the posttranslational modification such as ubiquitination regulation and control, from anthocyanin to harmful free radicals
Eliminate, participate in the several kinds of mineral elements ion and vitamin confactor Cofacter (s), P53 action targets of enzymic catalytic reaction
Matrix metalloproteinase MMP, hypoxia inducible factor HIF, MDM2 zinc finger protein (structure is easily distorted by heavy metal ion), miRNA
Nickase Dicer regulation and control are started with, and are proposed that " enclosing target " (Encircle Target) is theoretical and are expressed intervention stratege with P53.The present invention
The main biochemical mechanism of action of the activated complex includes:
MiRNA is the endogenic non-coding RNA of organism, and miRNA, which has, suppresses the function that tumour is formed.MiR-34 families
Member (including miR-34a and miR-34b/c) is p53 direct action target, and this effect can induce aging, apoptosis and cell
Cycle arrest.MiRNA precursors obtain through Dicer cleavages.Dicer is attached to dsRNA, and substantial amounts of cutting mRNA can be triggered anti-
Should.Have one group of conservative acid residues sites in each catalytic center of Dicer enzymes, they can combine a magnesium from
Son.In Dicer albumen, four conservative amino acid sites in each RNaseIII domain activities site can be with two
Individual metal ion (Mg2+Or Mn2+) be combined, Dicer albumen can utilize " bimetallic ion " mechanism (two-metal-
Ionmechanism RNA degradation reactions are catalyzed).
P53 is made sugared in cell by being adjusted to TIGAR (TP53 induces glycolysis and Apoptosis) expression negativity
Glycolysis is excessive, the mechanism that intracellular activity oxygen level rises and makes cancer cell that apoptosis occur, by supplementing bivalent metal ion (Mg2+
And Mn2+) and monovalent metallic ion (K+, Rb+), activation pyruvate kinase (pyruvate kinase, PK), in glycolysis system
In, it is the enzyme that catalysis forms second ATP reaction.In ATP and Mg2+Under participation, (the 6- of fructose-1, 6-diphosphate kinases 1
Phosphofructokinase1, PFK1) in glycolytic pathway, catalysis fructose-1, 6-diphosphate generation fructose 1,6-diphosphate
(Fructosel, 6bisphosphate, F-1,6-BP), accelerate second of phosphorylation reaction of glycolytic pathway.
One important function mechanism of p53 albumen is by suppressing hypoxia inducible factor (hypoxia inducible
Factor, HIF) and VEGF, the formation of fibroblast growth factor, prevent the effect machine of Tumor Angiongesis
System.In the case of normoxic, HIF-l α subunits keep relatively low water due to the degradation by Ubiquitin-proteasome
It is flat, and in the case of anoxic, the effect of Ubiquitin-proteasome is suppressed, and HIF-l α subunits keep higher level, is gone forward side by side
Enter nucleus to be combined with HIF-1 β subunits, form active HIF, activate target gene (such as VEGF, bFGF) downstream, mediate shape
Into a series of physiological reaction of adaptation anoxics, promote angiogenesis;When protooncogene activation, p53 albumen can directly with
HIF-1 α subunits combine, and cause HIF-1 α albumen to be degraded, so as to inhibit revascularization.
By observing for a long time, entity tumor is mainly in histanoxia area, and many tumor patients show blood red in various degree
The symptom of protein decreased, cell oxygen carrying deficiency, HIF activity can be aggravated, promote tumor vascular growth speed.Therefore present invention combination
Thing supplements Fe2+、Mn2+Intake, mainly by supplementing hemoglobin ferrous ion and Intramitochondrial manganese, increase hemoglobin
Synthesis, the activity of oxygenase is activated, strengthen blood oxygen concentration.Suppression of the nearly and complementary enhancing p53 to hypoxia inducible factor HIF.
The enhancing of oxonium ion, it helps Ubiquitin-proteasome maintains vigour, and makes HIF-l α subunits keep reduced levels.
P53 can activate the prolyl hydroxylase (prolyl hydroxylase, PHDs) of collagen, and the enzyme has anti-blood
Pipe formation characteristic, suppress revascularization.The catalytic reaction of prolyl hydroxylase needs Fe2+With ascorbate (vitamin C) ginseng
With.
Lysyl hydroxylase can make p53 hydroxylatings and prevent its acetylation, suppress its transcriptional activity.Lysine is hydroxylated
Enzyme (LOX) is that copper relies on monoamine oxidase, promotes the formation of covalent cross-linking in elastin laminin and collagenous fibres, makes outside tumour cell
Matrix, which ossifys, to be hardened, and prevents invasion and attack and DISTANT METASTASES IN of the tumour cell to surrounding tissue.Also there are some researches show LOX high expression
It is breast cancer infantile tumour stromal reaction, the LOX of secretion acts on collagen, stimulates tumour cell to stretch pseudopodium projection increase flesh and moves
Albumen polymerize, adhesion, improves flesh ball-actin crosslinking, promotes myofilament to shrink, so as to " the high speed as tumor cell migration
Highway ".The solution of the present invention is to pass through Mo2+Balance and suppression Cu2+Activity and absorb, suppress LOX to p53 hydroxyl
Change.By supplementing K+、Li+And Ca2+Fibrinolysin and kallikrein are activated, resolution improves fibrinolytic, reduces fiber in blood plasma
Protein content, reduce cancer embolus generation and tissue fibrosis risk.
MDM2 oncogenes are combined with p53, can reduce P53 expression.Mdm2 participates in the regulation of p53 negative feedback loops.Increase mdm2
Expression cause p53 exported out of core and the degraded of ubiquinone protein lytic pathway increase.It is can be found that in some p53 positive cancers
There is mdm2 to expand and be overexpressed.
MDM2 oncogene fingers --- zinc finger protein, Zn2+By Cd2+、Hg2+、Co2+、Cu2+Substituted, distort zinc finger
Structure, formed such as Cd5Zn2-MT hybrid metal albumen, it is near and heighten MDM2 amplification and overexpression, this also explain heavy metal from
Son can cause the carcinogenic principle of gene mutation, can also explain malignant tumour center site Cd2+、Hg2+Concentration increase, Cu/Zn
The reason for ratio dramatically increases compared with normal structure.Zn is added in active compound2+、Se2+、Mo2+, mainly replace and distort zinc finger
Cd in protein structure2+、Hg2+、Co2+、Cu2+, while suppress Metal Ions Cd2+、Hg2+、Co2+、Cu2+Absorption and enzymatic reaction
Activity.
The active compound of p53 expression of tumor suppressor gene is improved to a kind of target of the present invention with reference to specific embodiment
Thing is further described in detail, and technical scheme includes but is not limited to following examples.
Embodiment 1
It is a kind of to target the activated complex solution for improving p53 expression of tumor suppressor gene, the composition of the activated complex and contain
Amount is shown in Table 1.
The targeting of table 1 improves the composition of the activated complex of p53 expression of tumor suppressor gene
Composition | The symbol of element | Per 100ml | Ion concentration (mg/ml) |
Blueberry anthocyanin | 300mg | 3 | |
Iron | Fe | 5mg | 0.05 |
Calcium | Ca | 3mg | 0.03 |
Zinc | Zn | 2mg | 0.02 |
Selenium | Se | 10ug | 0.0001 |
Magnesium | Mg | 12mg | 0.12 |
Manganese | Mn | 45ug | 0.00045 |
Molybdenum | Mo | 10ug | 0.0001 |
Potassium | K | 20mg | 0.2 |
Rubidium | Rb | 20ug | 0.0002 |
Lithium | Li | 20ug | 0.0002 |
Wherein blueberry anthocyanin commission Daxing'an Mountainrange Lin Gebei psychrophiles Science and Technology Co., Ltd. processing, the blueberry
Anthocyanin is powdered, and wherein the mass content of anthocyanin is 45%.Wherein metal ion derives from contains Fe simultaneously2+、Ca2+、
Zn2+、Se2+、Mg2+、Mn2+、Mo2+、K+、Rb+、Li+Mineral matter purification active ionic water, commission Qingdao stretch the eastern limited public affairs of ore deposit liquid
It is prepared by department.
The present embodiment in use, blueberry anthocyanin powder is dissolved in mineral matter purification active ionic water, flower
Blue or green glycosides forms activated complex with metal ion-chelant.
Embodiment 2
It is a kind of to target the activated complex solution for improving p53 expression of tumor suppressor gene, the composition of the activated complex and contain
Amount is shown in Table 2.
The targeting of table 2 improves the composition of the activated complex of p53 expression of tumor suppressor gene
Composition | The symbol of element | Per 100ml | Ion concentration (mg/ml) |
Blueberry anthocyanin | 1g | 10 | |
Iron | Fe | 10mg | 0.1 |
Calcium | Ca | 30mg | 0.3 |
Zinc | Zn | 4mg | 0.04 |
Selenium | Se | 100ug | 0.001 |
Magnesium | Mg | 25mg | 0.25 |
Manganese | Mn | 50ug | 0.0005 |
Molybdenum | Mo | 20ug | 0.0002 |
Potassium | K | 40mg | 0.4 |
Rubidium | Rb | 20ug | 0.0002 |
Lithium | Li | 20ug | 0.0002 |
Wherein blueberry anthocyanin commission Daxing'an Mountainrange Lin Gebei psychrophiles Science and Technology Co., Ltd. processing, the blueberry
Anthocyanin is powdered, and wherein the mass content of anthocyanin is 30%.Wherein metal ion derives from contains Fe simultaneously2+、Ca2+、
Zn2+、Se2+、Mg2+、Mn2+、Mo2+、K+、Rb+、Li+Mineral matter purification active ionic water, commission Qingdao stretch the eastern limited public affairs of ore deposit liquid
It is prepared by department.
The present embodiment in use, blueberry anthocyanin powder is dissolved in mineral matter purification active ionic water, flower
Blue or green glycosides forms activated complex with metal ion-chelant.
Embodiment 3
It is a kind of to target the activated complex solution for improving p53 expression of tumor suppressor gene, the composition of the activated complex and contain
Amount is shown in Table 3.
The targeting of table 3 improves the composition of the activated complex of p53 expression of tumor suppressor gene
Composition | The symbol of element | Per 100ml | Ion concentration (mg/ml) |
Blueberry anthocyanin | 1g | 10 | |
Iron | Fe | 20mg | 0.2 |
Calcium | Ca | 500mg | 5 |
Zinc | Zn | 10mg | 0.1 |
Selenium | Se | 200ug | 0.002 |
Magnesium | Mg | 100mg | 1 |
Manganese | Mn | 1mg | 0.01 |
Molybdenum | Mo | 200ug | 0.002 |
Potassium | K | 100mg | 1 |
Rubidium | Rb | 500ug | 0.005 |
Lithium | Li | 100ug | 0.001 |
Wherein blueberry anthocyanin commission Daxing'an Mountainrange Lin Gebei psychrophiles Science and Technology Co., Ltd. processing, the blueberry
Anthocyanin is powdered, and wherein the mass content of anthocyanin is 5%.Wherein metal ion derives from contains Fe simultaneously2+、Ca2+、
Zn2+、Se2+、Mg2+、Mn2+、Mo2+、K+、Rb+、Li+Mineral matter purification active ionic water, commission Qingdao stretch the eastern limited public affairs of ore deposit liquid
It is prepared by department.
The present embodiment in use, blueberry anthocyanin powder is dissolved in mineral matter purification active ionic water, flower
Blue or green glycosides forms activated complex with metal ion-chelant.
Embodiment 4
Activated complex in embodiment 1 intervenes rehabilitation case.
Mr. Fu, 74 years old, people from Anhui, in August, 2016 was diagnosed as prostate cancer in Anhui hospital of provinces and cities, and PET-CT is shown entirely
The multiple Bone tumour of body.Pain is abnormal, inconvenient walking, the movement of roller chair.In August, 2016, through blood test, total prostate specific
Antigen has been above 10028.229ng/ml, free prostate gland specificity antigen 28.229ng/ml.Because patient's year gesture is with height,
Without more preferable therapeutic scheme, it is proposed that abandon treating, do deathbed care.In Shenzhen, the son of work introduces through friend, agrees to receive
The tentative activated complex taken in the embodiment of the present invention 1 of father is allowed to be intervened.Take once a day, each 50ml.Through
Spend 15 days and try out, examined again to Fuyang City the People's Hospital, surprisingly find that T-PSA recovers negative, be
0.181.Then, the activated complex 2 months taken in the embodiment of the present invention 1 is held, on January 25th, 2017, is entered in Taihe County
Row whole body PEC-CT imaging detections, find brain, eye socket, pharynx nasalis, neck, chest be not apparent from abnormal carbohydrate metabolism increase stove or
Obvious enlarged lymph node etc..Prostate without significantly increasing, reduced by Bone tumour site.Most significantly life change is that patient is no longer
Wheelchair is relied on, anodyne is eliminated the reliance on, can freely walk, diet is clearly better, and complexion takes a turn for the better, and has rosy cheeks, body weight has increasing.
Embodiment 5
Activated complex in embodiment 2 intervenes rehabilitation case.
Cervical cancer patient Mrs Liang, 40 years old, Cantonese, high-risk HPV virus caused DNA mutation, and 2016 in Shenzhen
The cervical carcinoma that South Mountain hospital is diagnosed as, and do Hysterectomy.Feel that somatic reaction is abnormal, goes to Zhongshan University in April, 2017
Attached tumour hospital is diagnosed as cervical cancer relapse, through clinical detection cent lymphocytes 0.591, lymphocyte absolute value 4.1.
It is tumor-marker analyte detection, Squamous intraepithelial lesion (SCC) 1.8ng/mL, carcinomebryonic antigen (CEA) 259.28ng/ again afterwards
ML, CA125 75.8U/mL.Agree to through patient and family members, sufferers themselves and family members agree to that the present invention is taken in receiving
The activated complex of embodiment 2 is intervened, and is taken once a day, each 50ml.After one week, patient substantially feels that action is strong,
After 10 days, Shenzhen people's hospital is gone to be detected, Squamous intraepithelial lesion (SCC) reverts to feminine gender, returns to
0.82ng/mL, cent lymphocytes 27.4, lymphocyte absolute value 2.36, revert to normal range (NR).Carcinomebryonic antigen
(CEA) 202.9ng/mL is dropped to, CA125 drops to 73.56U/mL.
Embodiment 6
Activated complex in embodiment 3 intervenes rehabilitation case.
Patients with lung cancer Mr. Lei, 58 years old, people from Hunan, on April 17th, 2017 was true by Hunan Bin Zhoushi First People's Hospital
Examine as right lung central type carcinoma of lung, with more bilateral rib destructions of bone, consider transfer, part Thoracolumbar disk high density tubercle, transfer is treated
Row.Right adrenal gland area low-density shadow, shifts the row for the treatment of.Chemotherapy is simultaneously done by Hou Fu Hong Kong Sanatorium & Hospitals, and PET-CT images are shown, pulmonary carcinosis
Become and Bone tumour canceration site is abnormal at totally 15.After receiving chemotherapy through Hong Kong, patient receives in Shenzhen's Luohu Hospital Group's again
Medical test, wherein white blood cell count(WBC) are only 1.74, platelet count 120, and neutrophil leucocyte ratio is 39.6, monocyte ratio
Value 10.3, neutrophil leucocyte absolute value 0.69, lymphocyte absolute number 0.85.Sufferers themselves and family members agree to that this hair is taken in receiving
Activated complex in bright embodiment 3, takes once a day, each 50ml.3 days or so time, patient substantially feel spiritual shape
State takes a turn for the better.After 30 days, Luohu Hospital Group's are arrived again and carry out blood testing and CT diagnosis, above dysimmunity index full recovery is
Normal range (NR), white blood cell count(WBC) 5.43, platelet count 211, neutrophil leucocyte ratio are 69.1, monocyte ratio 8.8,
Neutrophil leucocyte absolute value 3.75, lymphocyte absolute number 1.18.CT images show that right side adrenal area low-density shadow has disappeared
Lose.
Activated complex of the present invention passes through from Guangdong, Guangxi, Hong Kong, Anhui, Hunan, the Inner Mongol, Fujian 69 totally
The clinic trial intervention of position tumor patient, from anthocyanin harmful free radicals are eliminated, participated in the multi mineral member of enzymic catalytic reaction
Plain ion and vitamin confactor (Cofacter (s)), P53 action target matrix metalloproteinases MMP, hypoxia inducible factor
The regulation and control of HIF, MDM2 zinc finger protein (structure is easily distorted by heavy metal ion), miRNA nickases Dicer are started with, to P53 genes
" enclosing target " (Encircle Target) regulation is carried out, reverses repressed p53 activity in DNA methylation activation tumour cell, with
The increase of anthocyanin and composition Mineral Elements concentration and the increase of Time of Administration, p53 protein expressions dramatically increase,
P53 gene methylation situations significantly reduce.Compareed by the clinical intervention validity check of Grade A hospital, more than 65 blood samples of patients
Critical immune index, tumor markers index are obviously controlled or recover normal completely, there is 4 above the average age for marriage advanced tumor patients,
Comparison test index is not obtained.
In summary, activated complex of the present invention improves the active compound of p53 expression of tumor suppressor gene by targetting
Thing, more than enough can target and heighten the expression and effect of Suppressor p53, reach control cancer cell development, induction cancer cell aging and
Death, so as to realize the treatment to cancer.
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
For member, under the premise without departing from the principles of the invention, some improvements and modifications can also be made, these improvements and modifications also should
It is considered as protection scope of the present invention.
Claims (10)
1. it is a kind of target improve p53 expression of tumor suppressor gene activated complex, it is characterised in that the activated complex by including
The raw material chelating of following components obtains:Anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、Mg2 +、Mn2+、Mo2+、K+、Rb+And Li+In one or more.
2. a kind of target the activated complex solution for improving p53 expression of tumor suppressor gene, it is characterised in that the activated complex is molten
The solvent of liquid is water, and solute includes anthocyanin and metal ion;The metal ion includes Fe2+、Ca2+、Zn2+、Se2+、Mg2+、
Mn2+、Mo2+、K+、Rb+And Li+In one or more.
3. activated complex solution according to claim 2, it is characterised in that the anthocyanin is in activated complex solution
In concentration be 1~100mg/ml.
4. the activated complex solution according to Claims 2 or 3, it is characterised in that the anthocyanin is spent for plant extract
Blue or green glycosides, the plant include purple sweetpotato, grape, blood orange, red cabbage, blueberry, eggplant, cherry, the red certain kind of berries, strawberry, mulberries, hawthorn
With the one or more in morning glory.
5. activated complex solution according to claim 4, it is characterised in that anthocyanin in the plant extract anthocyanin
Mass content be 3~50%.
6. activated complex solution according to claim 2, it is characterised in that the metal ion is molten in activated complex
Concentration in liquid is as follows:Fe2+Concentration be 0.1~0.4mg/ml, Ca2+Concentration be 0.2~20mg/ml, Zn2+Concentration be
0.04~0.38mg/ml, Se2+Concentration be 0.0001~0.004mg/ml, Mg2+Concentration be 0.4~7mg/ml, Mn2+It is dense
Spend for 0.0004~0.06mg/ml, Mo2+Concentration be 0.0002~0.007mg/ml, K+Concentration be 0.4~112.5mg/
Ml, Rb+Concentration be 0.0004~0.0952mg/ml, Li+Concentration be 0.0004~0.012mg/ml.
7. activated complex solution according to claim 6, it is characterised in that the metal ion is molten in activated complex
Concentration in liquid is as follows:Fe2+Concentration be 0.2~0.3mg/ml, Ca2+Concentration be 0.5~15mg/ml, Zn2+Concentration be
0.15~0.28mg/ml, Se2+Concentration be 0.0002~0.003mg/ml, Mg2+Concentration be 1.5~6mg/ml, Mn2+It is dense
Spend for 0.01~0.05mg/ml, Mo2+Concentration be 0.0008~0.006mg/ml, K+Concentration be 5~100mg/ml, Rb+'s
Concentration is 0.002~0.08mg/ml, Li+Concentration be 0.001~0.012mg/ml.
8. activated complex solution according to claim 2, it is characterised in that the metal ion is derived from mineral matter
The active ionic water of purification.
9. activated complex solution according to claim 2, it is characterised in that the metal ion derives from and is rich in metal
The plant extracts of ion, including Fe2+Extract, Ca2+Extract, Zn2+Extract, Se2+Extract, Mg2+Extract, Mn2+
Extract, Mo2+Extract, K+Extract, Rb+Extract and Li+Extract.
10. activated complex solution according to claim 9, it is characterised in that the Fe2+Extract extracts for cherry
Thing, the Ca2+Extract is (0.9~1.1) including mass ratio:(0.9~1.1) Thallus Laminariae (Thallus Eckloniae) extract and Herba Apii graveolentis extract;It is described
Zn2+Extract includes mass ratio (0.9~1.1):(0.9~1.1):The Abelmoschus Esculentus Linn extract of (0.9~1.1), blueberry extract
With male silk moth extract;The Se2+Extract, Rb+Extract is marine algae extract;The Mg2+Extract includes mass ratio
(0.9~1.1):(0.9~1.1):Hazel extract, Semen phaseoli radiati extract and the thyme extract of (0.9~1.1);The Mn2+
Extract includes mass ratio (0.9~1.1):The Echinacea Purpurea Herb P.E and green-tea extract of (0.9~1.1);The Mo2+Extract
For extract of soybean;The K+Extract includes mass ratio (0.9~1.1):(0.9~1.1):(0.9~1.1):(0.9~
1.1) Thallus Laminariae (Thallus Eckloniae) extract, banana extract, peppermint leaf extract and wax gourd extract;The Li+Extract is to spread out numbness
Tea extraction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710914788.0A CN107569514A (en) | 2017-09-30 | 2017-09-30 | It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710914788.0A CN107569514A (en) | 2017-09-30 | 2017-09-30 | It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107569514A true CN107569514A (en) | 2018-01-12 |
Family
ID=61039798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710914788.0A Pending CN107569514A (en) | 2017-09-30 | 2017-09-30 | It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107569514A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824746A (en) * | 2005-12-28 | 2006-08-30 | 沈波涛 | OPC nutrition reinforced grape wine |
CN102093939A (en) * | 2010-11-29 | 2011-06-15 | 高思 | Nutrition-enhanced health-care wine prepared from plant containing natural biological antioxidant |
CN102202815A (en) * | 2008-05-16 | 2011-09-28 | 维鲁泰克技术股份有限公司 | Green synthesis of nanometals using plant extracts and use thereof |
CN106491641A (en) * | 2016-10-28 | 2017-03-15 | 乌林奇 | A kind of compsn. consisting of influenza virus surface of targeting preventing and treating cerebral thrombosiss and application |
CN106551383A (en) * | 2015-09-21 | 2017-04-05 | 北京倍和阳光科技发展有限公司 | A kind of antioxidant composition of strong anti-oxidation |
-
2017
- 2017-09-30 CN CN201710914788.0A patent/CN107569514A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824746A (en) * | 2005-12-28 | 2006-08-30 | 沈波涛 | OPC nutrition reinforced grape wine |
CN102202815A (en) * | 2008-05-16 | 2011-09-28 | 维鲁泰克技术股份有限公司 | Green synthesis of nanometals using plant extracts and use thereof |
CN102093939A (en) * | 2010-11-29 | 2011-06-15 | 高思 | Nutrition-enhanced health-care wine prepared from plant containing natural biological antioxidant |
CN106551383A (en) * | 2015-09-21 | 2017-04-05 | 北京倍和阳光科技发展有限公司 | A kind of antioxidant composition of strong anti-oxidation |
CN106491641A (en) * | 2016-10-28 | 2017-03-15 | 乌林奇 | A kind of compsn. consisting of influenza virus surface of targeting preventing and treating cerebral thrombosiss and application |
Non-Patent Citations (9)
Title |
---|
HUANG HUI-PEI等: "Anthocyanin-rich Mulberry extract inhibit the gastric cancer cell growth in vitro and xenograft mice by inducing signals", 《FOOD CHEMISTRY》 * |
刘莉: "《蔬菜营养学》", 30 June 2014, 天津大学出版社 * |
徐志坚等: "《不生癌的智慧 大字版》", 31 December 2015, 中国盲文出版社 * |
李巨秀等: "石榴花色苷的微波辅助提取及抗氧化活性研究", 《食品科学》 * |
杨玉红: "《食品化学》", 30 September 2012, 中国轻工业出版社 * |
迟广训等: "《发酵式养生法》", 30 November 2014, 中医古籍出版社 * |
邵颖等: "《食品生物化学》", 31 August 2015, 中国轻工业出版社 * |
郭松涛: "《人生保健 上册》", 29 February 2012, 中医古籍出版社 * |
陈洋等: "基于原子力显微镜研究p53蛋白与PBR322_DNA的相互作用", 《山东科学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | Anti‐invasion effect of rosmarinic acid via the extracellular signal‐regulated kinase and oxidation–reduction pathway in Ls174‐T cells | |
Tong et al. | Synergistic antitumor effect of dichloroacetate in combination with 5‐fluorouracil in colorectal cancer | |
Wu et al. | In vitro and in vivo study of phloretin‐induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter | |
Ma et al. | Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis | |
Pu et al. | Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs | |
Pan et al. | Hedyotis diffusa plus Scutellaria barbata Induce Bladder Cancer Cell Apoptosis by Inhibiting Akt Signaling Pathway through Downregulating miR‐155 Expression | |
Yang et al. | Curcumin and glu‐GNPs induce radiosensitivity against breast cancer stem‐like cells | |
Wang et al. | Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation | |
Fei et al. | Capilliposide isolated from Lysimachia capillipes Hemsl. induces ROS generation, cell cycle arrest, and apoptosis in human nonsmall cell lung cancer cell lines | |
Cheng et al. | Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer | |
Shen et al. | Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo | |
CN107419004A (en) | LncRNA RP11 290F20.3 and its siRNA application | |
Chandimali et al. | BRM270 suppresses cervical cancer stem cell characteristics and progression by inhibiting SOX2 | |
Deng et al. | Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases | |
Khazal et al. | Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis | |
Zong et al. | SIK2 promotes cisplatin resistance induced by aerobic glycolysis in breast cancer cells through PI3K/AKT/mTOR signaling pathway | |
Song et al. | Moderate Static Magnet fields suppress ovarian cancer metastasis via ROS‐mediated oxidative stress | |
Haiyan et al. | Growth of breast cancer cells inhibited by bromelains extracted from the different tissues of pineapple | |
Isobe et al. | A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG) | |
Zhang et al. | Combined Effects of 2‐Methoxyestradiol (Hypoxia‐Inducible Factor 1α Inhibitor) and Dasatinib (A Second‐Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells | |
Muramaki et al. | Chemosensitization of gemcitabine‐resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti‐apoptotic gene, clusterin | |
Liu et al. | HTBPI, an active phenanthroindolizidine alkaloid, inhibits liver tumorigenesis by targeting Akt | |
CN115837018B (en) | Application of 3-hydroxy morinda quinone in preparation of breast cancer resisting medicine | |
CN107569514A (en) | It is a kind of to target the activated complex for improving p53 expression of tumor suppressor gene | |
Zhang et al. | PPTS Inhibits the TGF‐β1‐Induced Epithelial‐Mesenchymal Transition in Human Colorectal Cancer SW480 Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180112 |